Action of anti-HIV drugs and resistance: reverse transcriptase inhibitors and protease inhibitors
T Imamichi - Current pharmaceutical design, 2004 - ingentaconnect.com
Currently, 20 drugs have been approved for Human Immunodeficiency Virus type-1 (HIV-1)
clinical therapy. These drugs inhibit HIV-1 reverse transcriptase, protease, or virus entry …
clinical therapy. These drugs inhibit HIV-1 reverse transcriptase, protease, or virus entry …
Action of Anti-HIV Drugs and Resistance: Reverse Transcriptase Inhibitors and Protease Inhibitors
T Imamichi - Current Pharmaceutical Design, 2004 - search.proquest.com
Currently, 20 drugs have been approved for Human Immunodeficiency Virus type-1 (HIV-1)
clinical therapy. These drugs inhibit HIV-1 reverse transcriptase, protease, or virus entry …
clinical therapy. These drugs inhibit HIV-1 reverse transcriptase, protease, or virus entry …
[引用][C] Action of anti-HIV drugs and resistance: Reverse transcriptase inhibitors and protease inhibitors
T IMAMICHI - Current pharmaceutical design, 2004 - pascal-francis.inist.fr
Action of anti-HIV drugs and resistance: Reverse transcriptase inhibitors and protease
inhibitors CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
inhibitors CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
Action of anti-HIV drugs and resistance: reverse transcriptase inhibitors and protease inhibitors.
T Imamichi - Current Pharmaceutical Design, 2004 - europepmc.org
Currently, 20 drugs have been approved for Human Immunodeficiency Virus type-1 (HIV-1)
clinical therapy. These drugs inhibit HIV-1 reverse transcriptase, protease, or virus entry …
clinical therapy. These drugs inhibit HIV-1 reverse transcriptase, protease, or virus entry …
Action of anti-HIV drugs and resistance: reverse transcriptase inhibitors and protease inhibitors
T Imamichi - Current pharmaceutical design, 2004 - pubmed.ncbi.nlm.nih.gov
Currently, 20 drugs have been approved for Human Immunodeficiency Virus type-1 (HIV-1)
clinical therapy. These drugs inhibit HIV-1 reverse transcriptase, protease, or virus entry …
clinical therapy. These drugs inhibit HIV-1 reverse transcriptase, protease, or virus entry …
[PDF][PDF] Action of Anti-HIV Drugs and Resistance: Reverse Transcriptase Inhibitors and Protease Inhibitors
T Imamichi - Current Pharmaceutical Design, 2004 - researchgate.net
Currently, 20 drugs have been approved for Human Immunodeficiency Virus type-1 (HIV-1)
clinical therapy. These drugs inhibit HIV-1 reverse transcriptase, protease, or virus entry …
clinical therapy. These drugs inhibit HIV-1 reverse transcriptase, protease, or virus entry …
[引用][C] Action of Anti-HIV Drugs and Resistance: Reverse Transcriptase Inhibitors and Protease Inhibitors
T Imamichi - Current Pharmaceutical Design, 2004 - cir.nii.ac.jp
Action of Anti-HIV Drugs and Resistance: Reverse Transcriptase Inhibitors and Protease
Inhibitors | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
Inhibitors | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …